Blogs

Metabolomics 101 - From Experimental Design and Sample Preparation to Data Quality, Data Standards and Data Sharing Overall goals

Submitted by Reza on Sat, 06/06/2015 - 13:21

This Workshop is organized by COSMOS and the Data Standards Task Group of the Metabolomics Society presenting during the annual Metabolomics Society conference in San Francisco June 2015

Join is our workshop: http://metabolomics2015.org/index.php/program/oral-presentations-detail/...

First Brazilian Workshop on Bioinformatics/Chemometrics for Metabolomics 13th - 14th March 2015

Submitted by Reza on Sat, 02/14/2015 - 17:15

The First Brazilian Workshop on Bioinformatics/Chemometrics for Metabolomics aims to group expertise on metabolomics data analysis spread in different science fields in the Brazilian community. It is also an attempt to strength community collaboration, exchanging resources and knowledge through the community mapping. The event is open to all scientific community. COSMOS will present "Data sharing and standards in metabolomics: What we can learn from other “omics” by Reza Salek"

EXPERT CENTER FOR METABOLOMICS

Submitted by Reza on Fri, 01/30/2015 - 17:35

Having identified the benefits of metabolomics approaches for sample quality evaluation, various COSMOS partners, as well as some other private and public stakeholders, have established a consortium of institutions involved in metabolomics activities as a follow-up of the implementation of a working group between the NMR metabolomics working group of COSMOS and BioMedBridges described in Deliverable 6.2 (see the COSMOS website).

Biomarkers for Brain Disorders: Challenges and Opportunities 1-3 February 2015 Wellcome Trust Genome Campus, Cambridge, UK

Submitted by Reza on Wed, 01/14/2015 - 07:45

The 3rd Wellcome Trust Scientific Conference on Biomarkers for Brain Disorders: Challenges and Opportunities was held at Wellcome Trust Genome Campus, Cambridge, UK. The discovery and validation of biomarkers across neuroscience is an important challenge for early diagnosis of disease and for the development of therapeutics.

Pages